(Q64898378)

30 June 2019

review article

1 reference

title

Sequential antibiotic therapy: the right patient, the right time and the right outcome. (English)

1 reference

30 June 2019

1 reference

P Davey

1

1 reference

30 June 2019

D Nathwani

series ordinal

2

1 reference

30 June 2019

publication date

1 July 1998

1 reference

30 June 2019

published in

Journal of Infection

1 reference

30 June 2019

volume

37 Suppl 1

1 reference

30 June 2019

page(s)

37-44

1 reference

30 June 2019

A comparison of the costs of ceftazidime therapy and gentamicin combinations in three UK hospitals

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Prospective cost analysis of moxalactam versus clindamycin plus gentamicin for endomyometritis after cesarean section

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Computerised calculation of the true costs of antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Technique for calculation of the true costs of antibiotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Why do patients with infection remain in hospital once changed to oral antibiotics?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Intravenous antimicrobial therapy in the community: underused, inadequately resourced, or irrelevant to health care in Britain?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Pharmacoeconomics of intravenous drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Prospective audit of costs and outcome of aminoglycoside treatment and of therapy for gram-negative bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Pharmacoeconomics of antibacterial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

A simple index to identify occult bacterial infection in adults with acute unexplained fever

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Fever in hospitalized medical patients: characteristics and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Sequential antibiotic therapy: Effective cost management and patient care

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Enteric absorption of ciprofloxacin during the immediate postoperative period

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Impact of an infection consultation service for bacteraemia on clinical management and use of resources

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

The economic impact of infections. An analysis of hospital costs and charges in surgical patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Survey of antibiotic prescribing in a district general hospital. II. Lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

Duration of antibiotic courses for neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

An audit of ciprofloxacin use in a district general hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

The cost effectiveness of drug utilisation review in an outpatient setting

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2992732-3

7 January 2021

10.1016/S0163-4453(98)92732-3

Identifiers

DOI

1 reference

30 June 2019

1 reference

30 June 2019